# A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).

> **NCT02737319** · PHASE4 · COMPLETED · sponsor: **University of Sao Paulo** · enrollment: 493 (actual)

## Conditions studied

- Nephropathy

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT02737319
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2016-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737319, "A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02737319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*